Convert ICD-9-CM Diagnosis 995.29 to ICD-10-CM

ICD-9-CM 995.29 converts approximately to:
  • 2019 ICD-10-CM T36.0X5A Adverse effect of penicillins, initial encounter
    or:
  • 2019 ICD-10-CM T36.1X5A Adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter
    or:
  • 2019 ICD-10-CM T36.2X5A Adverse effect of chloramphenicol group, initial encounter
    or:
  • 2019 ICD-10-CM T36.3X5A Adverse effect of macrolides, initial encounter
    or:
  • 2019 ICD-10-CM T36.4X5A Adverse effect of tetracyclines, initial encounter
    or:
  • 2019 ICD-10-CM T36.5X5A Adverse effect of aminoglycosides, initial encounter
    or:
  • 2019 ICD-10-CM T36.6X5A Adverse effect of rifampicins, initial encounter
    or:
  • 2019 ICD-10-CM T36.7X5A Adverse effect of antifungal antibiotics, systemically used, initial encounter
    or:
  • 2019 ICD-10-CM T36.8X5A Adverse effect of other systemic antibiotics, initial encounter
    or:
  • 2019 ICD-10-CM T36.95XA Adverse effect of unspecified systemic antibiotic, initial encounter
    or:
  • 2019 ICD-10-CM T37.0X5A Adverse effect of sulfonamides, initial encounter
    or:
  • 2019 ICD-10-CM T37.1X5A Adverse effect of antimycobacterial drugs, initial encounter
    or:
  • 2019 ICD-10-CM T37.2X5A Adverse effect of antimalarials and drugs acting on other blood protozoa, initial encounter
    or:
  • 2019 ICD-10-CM T37.3X5A Adverse effect of other antiprotozoal drugs, initial encounter
    or:
  • 2019 ICD-10-CM T37.4X5A Adverse effect of anthelminthics, initial encounter
    or:
  • 2019 ICD-10-CM T37.5X5A Adverse effect of antiviral drugs, initial encounter
    or:
  • 2019 ICD-10-CM T37.8X5A Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter
    or:
  • 2019 ICD-10-CM T37.95XA Adverse effect of unspecified systemic anti-infective and antiparasitic, initial encounter
    or:
  • 2019 ICD-10-CM T38.0X5A Adverse effect of glucocorticoids and synthetic analogues, initial encounter
    or:
  • 2019 ICD-10-CM T38.1X5A Adverse effect of thyroid hormones and substitutes, initial encounter
    or:
  • 2019 ICD-10-CM T38.2X5A Adverse effect of antithyroid drugs, initial encounter
    or:
  • 2019 ICD-10-CM T38.4X5A Adverse effect of oral contraceptives, initial encounter
    or:
  • 2019 ICD-10-CM T38.5X5A Adverse effect of other estrogens and progestogens, initial encounter
    or:
  • 2019 ICD-10-CM T38.6X5A Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter
    or:
  • 2019 ICD-10-CM T38.7X5A Adverse effect of androgens and anabolic congeners, initial encounter
    or:
  • 2019 ICD-10-CM T38.805A Adverse effect of unspecified hormones and synthetic substitutes, initial encounter
    or:
  • 2019 ICD-10-CM T38.815A Adverse effect of anterior pituitary [adenohypophyseal] hormones, initial encounter
    or:
  • 2019 ICD-10-CM T38.895A Adverse effect of other hormones and synthetic substitutes, initial encounter
    or:
  • 2019 ICD-10-CM T38.905A Adverse effect of unspecified hormone antagonists, initial encounter
    or:
  • 2019 ICD-10-CM T38.995A Adverse effect of other hormone antagonists, initial encounter
    or:
  • 2019 ICD-10-CM T39.015A Adverse effect of aspirin, initial encounter
    or:
  • 2019 ICD-10-CM T39.095A Adverse effect of salicylates, initial encounter
    or:
  • 2019 ICD-10-CM T39.1X5A Adverse effect of 4-Aminophenol derivatives, initial encounter
    or:
  • 2019 ICD-10-CM T39.2X5A Adverse effect of pyrazolone derivatives, initial encounter
    or:
  • 2019 ICD-10-CM T39.315A Adverse effect of propionic acid derivatives, initial encounter
    or:
  • 2019 ICD-10-CM T39.395A Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
    or:
  • 2019 ICD-10-CM T39.4X5A Adverse effect of antirheumatics, not elsewhere classified, initial encounter
    or:
  • 2019 ICD-10-CM T39.8X5A Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter
    or:
  • 2019 ICD-10-CM T39.95XA Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter
    or:
  • 2019 ICD-10-CM T40.0X5A Adverse effect of opium, initial encounter
    or:
  • 2019 ICD-10-CM T40.2X5A Adverse effect of other opioids, initial encounter
    or:
  • 2019 ICD-10-CM T40.3X5A Adverse effect of methadone, initial encounter
    or:
  • 2019 ICD-10-CM T40.4X5A Adverse effect of other synthetic narcotics, initial encounter
    or:
  • 2019 ICD-10-CM T40.5X5A Adverse effect of cocaine, initial encounter
    or:
  • 2019 ICD-10-CM T40.605A Adverse effect of unspecified narcotics, initial encounter
    or:
  • 2019 ICD-10-CM T40.695A Adverse effect of other narcotics, initial encounter
    or:
  • 2019 ICD-10-CM T40.7X5A Adverse effect of cannabis (derivatives), initial encounter
    or:
  • 2019 ICD-10-CM T40.905A Adverse effect of unspecified psychodysleptics [hallucinogens], initial encounter
    or:
  • 2019 ICD-10-CM T40.995A Adverse effect of other psychodysleptics [hallucinogens], initial encounter
    or:
  • 2019 ICD-10-CM T41.5X5A Adverse effect of therapeutic gases, initial encounter
    or:
  • 2019 ICD-10-CM T42.0X5A Adverse effect of hydantoin derivatives, initial encounter
    or:
  • 2019 ICD-10-CM T42.1X5A Adverse effect of iminostilbenes, initial encounter
    or:
  • 2019 ICD-10-CM T42.2X5A Adverse effect of succinimides and oxazolidinediones, initial encounter
    or:
  • 2019 ICD-10-CM T42.3X5A Adverse effect of barbiturates, initial encounter
    or:
  • 2019 ICD-10-CM T42.4X5A Adverse effect of benzodiazepines, initial encounter
    or:
  • 2019 ICD-10-CM T42.5X5A Adverse effect of mixed antiepileptics, initial encounter
    or:
  • 2019 ICD-10-CM T42.6X5A Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter
    or:
  • 2019 ICD-10-CM T42.75XA Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter
    or:
  • 2019 ICD-10-CM T42.8X5A Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter
    or:
  • 2019 ICD-10-CM T43.015A Adverse effect of tricyclic antidepressants, initial encounter
    or:
  • 2019 ICD-10-CM T43.025A Adverse effect of tetracyclic antidepressants, initial encounter
    or:
  • 2019 ICD-10-CM T43.1X5A Adverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter
    or:
  • 2019 ICD-10-CM T43.205A Adverse effect of unspecified antidepressants, initial encounter
    or:
  • 2019 ICD-10-CM T43.215A Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
    or:
  • 2019 ICD-10-CM T43.225A Adverse effect of selective serotonin reuptake inhibitors, initial encounter
    or:
  • 2019 ICD-10-CM T43.295A Adverse effect of other antidepressants, initial encounter
    or:
  • 2019 ICD-10-CM T43.3X5A Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter
    or:
  • 2019 ICD-10-CM T43.4X5A Adverse effect of butyrophenone and thiothixene neuroleptics, initial encounter
    or:
  • 2019 ICD-10-CM T43.505A Adverse effect of unspecified antipsychotics and neuroleptics, initial encounter
    or:
  • 2019 ICD-10-CM T43.595A Adverse effect of other antipsychotics and neuroleptics, initial encounter
    or:
  • 2019 ICD-10-CM T43.605A Adverse effect of unspecified psychostimulants, initial encounter
    or:
  • 2019 ICD-10-CM T43.615A Adverse effect of caffeine, initial encounter
    or:
  • 2019 ICD-10-CM T43.625A Adverse effect of amphetamines, initial encounter
    or:
  • 2019 ICD-10-CM T43.635A Adverse effect of methylphenidate, initial encounter
    or:
  • 2019 ICD-10-CM T43.695A Adverse effect of other psychostimulants, initial encounter
    or:
  • 2019 ICD-10-CM T43.8X5A Adverse effect of other psychotropic drugs, initial encounter
    or:
  • 2019 ICD-10-CM T43.95XA Adverse effect of unspecified psychotropic drug, initial encounter
    or:
  • 2019 ICD-10-CM T44.0X5A Adverse effect of anticholinesterase agents, initial encounter
    or:
  • 2019 ICD-10-CM T44.1X5A Adverse effect of other parasympathomimetics [cholinergics], initial encounter
    or:
  • 2019 ICD-10-CM T44.2X5A Adverse effect of ganglionic blocking drugs, initial encounter
    or:
  • 2019 ICD-10-CM T44.3X5A Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
    or:
  • 2019 ICD-10-CM T44.4X5A Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter
    or:
  • 2019 ICD-10-CM T44.5X5A Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter
    or:
  • 2019 ICD-10-CM T44.6X5A Adverse effect of alpha-adrenoreceptor antagonists, initial encounter
    or:
  • 2019 ICD-10-CM T44.7X5A Adverse effect of beta-adrenoreceptor antagonists, initial encounter
    or:
  • 2019 ICD-10-CM T44.8X5A Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter
    or:
  • 2019 ICD-10-CM T44.905A Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter
    or:
  • 2019 ICD-10-CM T45.0X5A Adverse effect of antiallergic and antiemetic drugs, initial encounter
    or:
  • 2019 ICD-10-CM T45.1X5A Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
    or:
  • 2019 ICD-10-CM T45.2X5A Adverse effect of vitamins, initial encounter
    or:
  • 2019 ICD-10-CM T45.3X5A Adverse effect of enzymes, initial encounter
    or:
  • 2019 ICD-10-CM T45.4X5A Adverse effect of iron and its compounds, initial encounter
    or:
  • 2019 ICD-10-CM T45.515A Adverse effect of anticoagulants, initial encounter
    or:
  • 2019 ICD-10-CM T45.525A Adverse effect of antithrombotic drugs, initial encounter
    or:
  • 2019 ICD-10-CM T45.605A Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter
    or:
  • 2019 ICD-10-CM T45.615A Adverse effect of thrombolytic drugs, initial encounter
    or:
  • 2019 ICD-10-CM T45.625A Adverse effect of hemostatic drug, initial encounter
    or:
  • 2019 ICD-10-CM T45.695A Adverse effect of other fibrinolysis-affecting drugs, initial encounter
    or:
  • 2019 ICD-10-CM T45.7X5A Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
    or:
  • 2019 ICD-10-CM T45.8X5A Adverse effect of other primarily systemic and hematological agents, initial encounter
    or:
  • 2019 ICD-10-CM T45.95XA Adverse effect of unspecified primarily systemic and hematological agent, initial encounter
    or:
  • 2019 ICD-10-CM T46.0X5A Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
    or:
  • 2019 ICD-10-CM T46.1X5A Adverse effect of calcium-channel blockers, initial encounter
    or:
  • 2019 ICD-10-CM T46.2X5A Adverse effect of other antidysrhythmic drugs, initial encounter
    or:
  • 2019 ICD-10-CM T46.3X5A Adverse effect of coronary vasodilators, initial encounter
    or:
  • 2019 ICD-10-CM T46.4X5A Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
    or:
  • 2019 ICD-10-CM T46.5X5A Adverse effect of other antihypertensive drugs, initial encounter
    or:
  • 2019 ICD-10-CM T46.6X5A Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
    or:
  • 2019 ICD-10-CM T46.7X5A Adverse effect of peripheral vasodilators, initial encounter
    or:
  • 2019 ICD-10-CM T46.8X5A Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter
    or:
  • 2019 ICD-10-CM T46.905A Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
    or:
  • 2019 ICD-10-CM T46.995A Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter
    or:
  • 2019 ICD-10-CM T47.0X5A Adverse effect of histamine H2-receptor blockers, initial encounter
    or:
  • 2019 ICD-10-CM T47.1X5A Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
    or:
  • 2019 ICD-10-CM T47.2X5A Adverse effect of stimulant laxatives, initial encounter
    or:
  • 2019 ICD-10-CM T47.3X5A Adverse effect of saline and osmotic laxatives, initial encounter
    or:
  • 2019 ICD-10-CM T47.4X5A Adverse effect of other laxatives, initial encounter
    or:
  • 2019 ICD-10-CM T47.5X5A Adverse effect of digestants, initial encounter
    or:
  • 2019 ICD-10-CM T47.6X5A Adverse effect of antidiarrheal drugs, initial encounter
    or:
  • 2019 ICD-10-CM T47.7X5A Adverse effect of emetics, initial encounter
    or:
  • 2019 ICD-10-CM T47.8X5A Adverse effect of other agents primarily affecting gastrointestinal system, initial encounter
    or:
  • 2019 ICD-10-CM T47.95XA Adverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter
    or:
  • 2019 ICD-10-CM T48.0X5A Adverse effect of oxytocic drugs, initial encounter
    or:
  • 2019 ICD-10-CM T48.1X5A Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
    or:
  • 2019 ICD-10-CM T48.205A Adverse effect of unspecified drugs acting on muscles, initial encounter
    or:
  • 2019 ICD-10-CM T48.295A Adverse effect of other drugs acting on muscles, initial encounter
    or:
  • 2019 ICD-10-CM T48.3X5A Adverse effect of antitussives, initial encounter
    or:
  • 2019 ICD-10-CM T48.4X5A Adverse effect of expectorants, initial encounter
    or:
  • 2019 ICD-10-CM T48.5X5A Adverse effect of other anti-common-cold drugs, initial encounter
    or:
  • 2019 ICD-10-CM T48.6X5A Adverse effect of antiasthmatics, initial encounter
    or:
  • 2019 ICD-10-CM T48.905A Adverse effect of unspecified agents primarily acting on the respiratory system, initial encounter
    or:
  • 2019 ICD-10-CM T48.995A Adverse effect of other agents primarily acting on the respiratory system, initial encounter
    or:
  • 2019 ICD-10-CM T49.0X5A Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
    or:
  • 2019 ICD-10-CM T49.1X5A Adverse effect of antipruritics, initial encounter
    or:
  • 2019 ICD-10-CM T49.2X5A Adverse effect of local astringents and local detergents, initial encounter
    or:
  • 2019 ICD-10-CM T49.3X5A Adverse effect of emollients, demulcents and protectants, initial encounter
    or:
  • 2019 ICD-10-CM T49.4X5A Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
    or:
  • 2019 ICD-10-CM T49.5X5A Adverse effect of ophthalmological drugs and preparations, initial encounter
    or:
  • 2019 ICD-10-CM T49.6X5A Adverse effect of otorhinolaryngological drugs and preparations, initial encounter
    or:
  • 2019 ICD-10-CM T49.7X5A Adverse effect of dental drugs, topically applied, initial encounter
    or:
  • 2019 ICD-10-CM T49.8X5A Adverse effect of other topical agents, initial encounter
    or:
  • 2019 ICD-10-CM T49.95XA Adverse effect of unspecified topical agent, initial encounter
    or:
  • 2019 ICD-10-CM T50.0X5A Adverse effect of mineralocorticoids and their antagonists, initial encounter
    or:
  • 2019 ICD-10-CM T50.1X5A Adverse effect of loop [high-ceiling] diuretics, initial encounter
    or:
  • 2019 ICD-10-CM T50.2X5A Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
    or:
  • 2019 ICD-10-CM T50.3X5A Adverse effect of electrolytic, caloric and water-balance agents, initial encounter
    or:
  • 2019 ICD-10-CM T50.4X5A Adverse effect of drugs affecting uric acid metabolism, initial encounter
    or:
  • 2019 ICD-10-CM T50.5X5A Adverse effect of appetite depressants, initial encounter
    or:
  • 2019 ICD-10-CM T50.6X5A Adverse effect of antidotes and chelating agents, initial encounter
    or:
  • 2019 ICD-10-CM T50.7X5A Adverse effect of analeptics and opioid receptor antagonists, initial encounter
    or:
  • 2019 ICD-10-CM T50.8X5A Adverse effect of diagnostic agents, initial encounter
    or:
  • 2019 ICD-10-CM T50.A15A Adverse effect of pertussis vaccine, including combinations with a pertussis component, initial encounter
    or:
  • 2019 ICD-10-CM T50.A25A Adverse effect of mixed bacterial vaccines without a pertussis component, initial encounter
    or:
  • 2019 ICD-10-CM T50.A95A Adverse effect of other bacterial vaccines, initial encounter
    or:
  • 2019 ICD-10-CM T50.B15A Adverse effect of smallpox vaccines, initial encounter
    or:
  • 2019 ICD-10-CM T50.B95A Adverse effect of other viral vaccines, initial encounter
    or:
  • 2019 ICD-10-CM T50.Z15A Adverse effect of immunoglobulin, initial encounter
    or:
  • 2019 ICD-10-CM T50.Z95A Adverse effect of other vaccines and biological substances, initial encounter
    or:
  • 2019 ICD-10-CM T50.995A Adverse effect of other drugs, medicaments and biological substances, initial encounter

Note: approximate conversions between ICD-9-CM codes and ICD-10-CM codes may require clinical interpretation in order to determine the most appropriate conversion code(s) for your specific coding situation.

Source: 2019 ICD-10-CM CMS General Equivalence Mappings.